HR Execs on the Move

TimkenSteel

www.timkensteel.com

 
TimkenSteel (NYSE: TMST) manufactures high-performance carbon and alloy steel products in Canton, OH serving demanding applications in automotive, energy and a variety of industrial end markets. The company is a premier U.S. producer of alloy steel bars (up to 16 inches in diameter), seamless mechanical tubing and precision components. In the business of making high-quality steel primarily from recycled materials for more than 100 years, TimkenSteel`s proven expertise contributes to the performance of our customers` products. The company employs approximately 2,055 people and had sales of $1.2 billion in 2019. 
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Daniel Halm
Senior Director of Sales and Customer Service Profile
Tara Sidel
Director of Total Rewards Profile
Kris Syrvalin
Executive Vice President, General Counsel and Chief Human Resources Officer Profile
William Bryan
Executive Vice President of Manufacturing and Supply Chain Profile
Kevin Raketich
Executive Vice President of Sales, Marketing and Business Development Profile

Similar Companies

SecureOne Data Solutions

SecureOne Data Solutions is a Phoenix, AZ-based company in the Business Services sector.

Osn Office Furniture

Osn Office Furniture is a Minneapolis, MN-based company in the Business Services sector.

Rib City Grill

Rib City Grill is a Fort Myers Beach, FL-based company in the Business Services sector.

CARB-X

CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.